Demonstration of decreased - Posterior cingulate perfusion in mild Alzheimer's disease by means of H215O positron emission tomography

European Journal of Nuclear Medicine

Volumn 24, Issue 6, 1997, Pages 670-673

  Ishii, Kazunari ^a   Sasaki, Masahiro ^a   Yamaji, Shigeru ^a   Sakamoto, Setsu ^a,b   Kitagaki, Hajime ^a   Mori, Etsuro ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Cerebral blood flow; Oxygen 15 labelled water; Positron emission tomography; Posterior cingulate gyrus

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PARIETAL LOBE; PERFUSION; POSITRON EMISSION TOMOGRAPHY; TEMPORAL LOBE;

AGED; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; FEMALE; GYRUS CINGULI; HUMANS; MALE; OXYGEN RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; WATER;

EID: 0030805536     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050104     Document Type: Article

References (11)

1. Herholz K, Perani D, Salmon E, et al. Comparability of FDG PET studies in probable Alzheimer's disease. J Nucl Med 1993; 34: 1460-1466.
2. Fukuyama H, Ogawa M, Yamauchi H, et al. Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med 1994; 15: 1-6.
3. Gemmell HG, Sharp PF, Besson JAO, Ebmeier KP, Smith FW. A comparison of Tc-99m-HMPAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia. Eur J Nucl Med 1988; 14: 463-466.
4. Ishii K, Kitagaki H, Kono M, Mori E. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown hy positron emission tomography. J Nucl Med 1996; 37: 1159-1165.
5. Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer's disease. Lancet 1994; 344: 895.
6. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis in Alzheimer's disease: report of the NlNCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944.
7. Morris JC. The Clinical Dementia Rating (CDR): current version and screening rules. Neurology 1993; 43: 2412-2414.
8. Hatazawa J, Fujita H, Kanno I, et al. Regional cerebral blood flow, blood volume, oxygen extraction fraction, and oxygen utilization rate in normal volunteers measured by the autoradiographic technique and the single breath inhalation method. Ann Nucl Med 1995; 9: 15-21.
9. Friston KJ, Holmes AP, Worsely KJ, Poline JB, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Human Brain Map 1995; 2: 189-210.
10. Burdette JH, Minoshima S, Borght TV, Tran DD, Kuhl DE. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology 1996; 198: 8327-843.
11. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. N Engl J Med 1996; 334: 752-758.